With Inside U Miami Medicine, we explore our academic medicine ecosystem. We chat with researchers making groundbreaking discoveries, changemakers toppling barriers, and physicians reimagining the future of health care. We tackle tough topics and delve into complex challenges. Join us for transformative conversations hosted by Henri R. Ford, M.D., M.H.A., dean and chief academic officer of the University of Miami Miller School of Medicine.
Q&A with spine surgeon Dr. Michael Wang: New technology, early intervention, healthy aging and more
For decades, spine surgeons have largely followed a familiarapproach: wait until a patient’s condition becomes severe enough to warrant an invasive operation. But what about patients, particularly younger patients, who are in pain and need relief, yet aren’t candidates for traditional surgery?
On the latest episode of Inside U Miami Medicine, Dean Henri Ford welcomes neurosurgeon Michael Wang, M.D., back to the podcast to explore new approaches to spine care and the technologies that could change when and how patients are treated.
Dr. Wang also answers questions submitted by listeners, fromwhether he still gets nervous to 3D printing in spine surgery and more!
14 Jul 2026
Multiple sclerosis breakthrough? Inside the stem cell research that could transform MS care
For patients with aggressive, treatment-resistant Multiple Sclerosis (MS), the disease can keep progressing even as therapies improve outcomes for others. On this episode of Inside U Miami Medicine, MS expert Dr. Flavia Nelson takes us inside one of the field's most promising frontiers: regenerative stem cell therapy. She breaks down the science behind the groundbreaking BEAT MS clinical trial that explores whether stem cells can slow MS progression and repair damage to the central nervous system. It's a compelling look at hoe research is pushing the boundaries of what's possible for MS patients.
3 Jun 2026
Treatment-resistant depression: A scientist's discovery may offer hope
What if blocking a particular brain receptor could help combat treatment-resistant depression?
Dean Henri Ford sits down with Kirill Martemyanov, Ph.D., to learn about a previously unrecognized brain receptor that may hold the key to treating major depressive disorder, including the treatment-resistant cases that leave so many patients without relief.
The findings, recently published in Nature, point toward a bold new approach to treating these disorders, one that may lead to entirely new class of therapies called “nanobodies.”
The results are striking.
Tune in to hear Dr. Martemyanov share the science, the journey to the discovery, and what this could mean for the future of mental health treatment.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
YouTube views
193,827
Score snapshot 15 Sept 2025
Apple Podcasts (US)
5.0 / 5
13 ratings
Spotify
5.0 / 5
6 ratings
Podcast Authority Score: 56 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
50
Social presence
0
YouTube
86
Engagement
71
Host of Inside U Miami Medicine?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
